Automation specialist a winner
23 October, 2002 by Pete YoungLab automation specialist Advanced Rapid Robotic Manufacturing (ARRM) is simultaneously winning professional accolades and expanding its revenue base.
'Baby' biotechs targeted by NSW seminar
21 October, 2002 by Iain ScottA free seminar has been set down for November 13 in Sydney, with the aim of letting young biotechnology companies into the secrets of developing management strategies that will allow them to survive adverse events.
Biota rejects Bigshop board demand
21 October, 2002 by Pete YoungA bid by Perth lawyer and financier Farooq Khan to force his way onto the board of Biota Holdings has been rejected by the drug discovery company.
Cash burn out, earnings in at Amrad
17 October, 2002 by Melissa TrudingerAmrad chairman Olaf O'Duill doesn't like it when companies use "cash burn" to absolve themselves of their spending, and wants Amrad to think about cash earned, he told the company's annual general meeting yesterday.
Challenger readies for Asia VC play
17 October, 2002 by David BinningThe Kerry Packer-backed financial services and venture capital (VC) group Challenger International is nearing the end of negotiations to form a biotech VC fund out of Singapore which will trawl for investment opportunities across Asia, Australia and New Zealand, the company revealed on Wednesday.
Challenger betting on biotech for super boom
16 October, 2002 by David BinningPerched at the top of the ABN Amro Building in the heart of Sydney's 'big end' of town, Sean Mordaunt, business development manager with Challenger International's Corporate Superannuation Fund, thrives on the manic energy pulsing through the busy business hub and the harbour below.
Xcell move disappoints stranded WA researchers
15 October, 2002 by Melissa TrudingerResearchers at the Optical and Biomedical Engineering Laboratory (OBEL) at the University of WA were left surprised and disappointed after a decision by Perth-based company Xcell Diagnostics to withdraw funding from the lab's skin cancer project, which aimed to develop a new optical pen probe technique for early detection of skin cancers.
Bio-IT hot topic at upcoming seminars
15 October, 2002 by Iain ScottResearch firm IDC is to host two breakfast briefings on the bio-IT industry, with a particular focus on Australia and the Asia-Pacific.
South Africans quick to pick up Iatia technology
15 October, 2002 by Melissa TrudingerIatia's QPe phase imaging technology proved popular at the recent International Congress on Electron Microscopy in Durban, South Africa, according to CEO Brian Powell.
Pi2 heads for the great outdoors
15 October, 2002 by Iain ScottSydney-based company Pi2 Limited has touted a new business strategy with two acquisitions, one in life sciences and the other in outdoor advertising.
AstraZeneca plans for growth in Qld natural products centre
15 October, 2002 by Pete YoungPharmaceutical company AstraZeneca plans to augment the Queensland-based natural product research centre in which it has invested $55 million since 1993.
Biota braces for showdown with 'corporate rationaliser'
14 October, 2002 by Pete YoungThe scene has been set for a possible showdown next month between the board of drug discovery company Biota Holdings and Perth businessman Farooq Khan.
Mattick resigns from Benitec board
09 October, 2002 by Melissa TrudingerThe co-director of Queensland's Institute for Molecular Bioscience>, Prof John Mattick, has resigned from his position on Benitec's board of directors while he is in Germany on a sabbatical.
CSIRO sackings rumours prompt warnings
02 October, 2002 by Pete YoungReported plans to sack up to 26 staff from CSIRO's Division of Land and Water have touched off warnings about the organisation's long-term health from Federal Opposition and union sources.
Personal flavour to Lemberg Medal win
02 October, 2002 by Iain ScottThe 2002 ASBMB Lemberg Medal has special significance for its recipient, Prof Philip Board of the Australian National University.
